Takeda to withdraw and refile shelf registration in Japan

Takeda Pharmaceutical Company Limited (TSE:4502) announced that it would withdraw its shelf registration statement filed on June 3, 2024, and file a new shelf registration statement in Japan. The decision was made to facilitate the issuance of new shares of common stock or the disposal of treasury shares in a timely and flexible manner to support the continued implementation of the company's long-term incentive plan (LTIP) for employees. The planned issuance is capped at JPY 220 billion. The issuance of new shares of common stock or disposition of treasury shares related to the Shelf Registration will be conducted based on the LTIP and is not intended to raise funds.